December 1, 2025- McKesson Corporation announced the publication of its first-ever Advancing Community Oncology Report, a comprehensive look at the trends influencing community-based oncology practices across the United States, combined with expert perspectives on the opportunities for physicians in these settings to shape the next era of patient care.
The report features findings from a double-blind national survey of over 100 community oncologists and more than 100 practice administrators and staff, as well as insights from McKesson’s inaugural Accelerate conference, which brought together more than 1,500 physicians, clinicians, practice leaders and industry experts to discuss the future of community-based care.
These insights uncover clear ways biopharma can collaborate with community practices to accelerate patient access to innovative therapies and strengthen the community oncology ecosystem. Opportunities for the greatest impact include:
- Accelerate adoption of novel and precision therapies
- Unlock access to community-based clinical trials
- Elevate care for changing patient needs
- Prepare community practices for technology-driven care
- Foster collaboration and innovation through McKesson Accelerate
Continue Reading from McKesson Corporation here.